Search
4 May 2023 | 10:30 a.m. - 12:00 p.m. (EDT)
Join the Hogan Lovells Life Sciences & Health Care team and guest speaker Henry Hadad, Senior Vice President and Deputy General Counsel of Bristol Myers Squibb, for a discussion on the...
07 December 2022 | 2:00 PM - 3:30 PM (JST)
Our 18th session was on "IP Transactions: Comparative discussion of royalty provisions and other key economic terms in license agreements". This is the second of a 2-part series, which...
16 November 2022 | 8:30 a.m. - 9:45 a.m. CET| 3:30 p.m. - 4:45 p.m. CST/HKT | 4:30 p.m. - 5:45 p.m. JST
Webinar No. 4: Life Sciences companies navigating the shifting patent landscape in China
06 October 2022 | 3:00 PM - 4:30 PM (JST)
Our 17th session will be on "IP Transactions: Due diligence and related issues". This is the first of a 2-part series, which covered due diligence, focusing on strategic and legal...
28 September 2022 | 8:30 a.m. - 10:00 a.m. BST | 9:30 a.m. - 11:00 a.m. CET | 3:30 p.m. - 5:00 p.m. CST | 4:30 p.m. - 6:00 p.m. JST
Webinar No. 3: Out-licensing to Chinese counterparties, including related necessary IP protections
20 January 2022 | 3:00 PM - 4:30 PM (JST)
Our tenth session will be the second of a two-part series on IP aspects of joint venture agreements, R&D agreements, collaboration agreements, and related contractual arrangements with...
09 December 2021 | 3:00 PM - 4:30 PM (JST)
Our ninth session was the first of a two-part series on IP aspects of joint venture agreements, R&D agreements, collaboration agreements, and related contractual arrangements with Dr...
15 September 2021 | 3:00 PM - 4:30 PM (JST)
Our sixth session was on the practical implications of Brexit on IP – exploitation, enforcement and exhaustion with Dr Frederick Ch'en, Stephen Bennett, Katie McConnell and Sahira...
